Skip to main content
SpringerLink
Log in

Analysis of Complement Activation by Nanoparticles

  • Protocol
  • First Online:
Characterization of Nanoparticles Intended for Drug Delivery

Part of the book series: Methods in Molecular Biology ((MIMB,volume 1682))

Abstract

The complement system is a group of proteins, which function in plasma to assist the innate immunity in rapid clearance of pathogens. The complement system also contributes to coordination of the adaptive immune response. Complement Activation Related Pseudo Allergy or CARPA is a life-threatening condition commonly reported with certain types of drugs and nanotechnology-based combination products. While CARPA symptoms are similar to that of anaphylaxis, the mechanism behind this pathology does not involve IgE and is mediated by the complement system. In vitro assays using serum or plasma derived from healthy donor volunteers correlate with the in vivo complement-mediated reactions, and therefore are helpful in understanding the propensity of a given drug formulation to cause CARPA in patients. In the first edition of this book, we have described an in vitro method for qualitative assessment of the complement activation by nanomaterials using western blotting. Herein, we present a similar method utilizing enzyme-linked immunoassay for quantitative analysis of the complement activation, and we compare the performance of this approach to that of the qualitative western blotting technique. The revised chapter also includes new details about nanoparticle sample preparation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Calame DG, Mueller-Ortiz SL, Wetsel RA (2016) Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection. Immunobiology 221(12):1407–1417. doi:10.1016/j.imbio.2016.07.004

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Szebeni J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Rampton D, Weiss G, Folkersen J (2015) Hypersensitivity to intravenous iron: classification, terminology, mechanisms and management. Br J Pharmacol 172(21):5025–5036. doi:10.1111/bph.13268

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Szebeni J, Storm G (2015) Complement activation as a bioequivalence issue relevant to the development of generic liposomes and other nanoparticulate drugs. Biochem Biophys Res Commun 468(3):490–497. doi:10.1016/j.bbrc.2015.06.177

    Article  CAS  PubMed  Google Scholar 

  4. Rampton D, Folkersen J, Fishbane S, Hedenus M, Howaldt S, Locatelli F, Patni S, Szebeni J, Weiss G (2014) Hypersensitivity reactions to intravenous iron: guidance for risk minimization and management. Haematologica 99(11):1671–1676. doi:10.3324/haematol.2014.111492

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Szebeni J (2014) Complement activation-related pseudoallergy: a stress reaction in blood triggered by nanomedicines and biologicals. Mol Immunol 61(2):163–173. doi:10.1016/j.molimm.2014.06.038

    Article  CAS  PubMed  Google Scholar 

  6. Reddy ST, van der Vlies AJ, Simeoni E, Angeli V, Randolph GJ, O'Neil CP, Lee LK, Swartz MA, Hubbell JA (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25(10):1159–1164. doi:10.1038/nbt1332

    Article  CAS  PubMed  Google Scholar 

  7. Moghimi SM, Wibroe PP, Szebeni J, Hunter AC (2013) Surfactant-mediated complement activation in beagle dogs. Int Immunopharmacol 17(1):33–34. doi:10.1016/j.intimp.2013.05.012

    Article  CAS  PubMed  Google Scholar 

  8. Szebeni J, Muggia F, Gabizon A, Barenholz Y (2011) Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. Adv Drug Deliv Rev 63(12):1020–1030. doi:10.1016/j.addr.2011.06.017

    Article  CAS  PubMed  Google Scholar 

  9. Shen L, Engelhardt JA, Hung G, Yee J, Kikkawa R, Matson J, Tayefeh B, Machemer T, Giclas PC, Henry SP (2016) Effects of repeated complement activation associated with chronic treatment of Cynomolgus monkeys with 2′-O-Methoxyethyl modified antisense oligonucleotide. Nucleic Acid Ther 26(4):236–249. doi:10.1089/nat.2015.0584

    Article  CAS  PubMed  Google Scholar 

  10. Shen L, Frazer-Abel A, Reynolds PR, Giclas PC, Chappell A, Pangburn MK, Younis H, Henry SP (2014) Mechanistic understanding for the greater sensitivity of monkeys to antisense oligonucleotide-mediated complement activation compared with humans. J Pharmacol Exp Ther 351(3):709–717. doi:10.1124/jpet.114.219378

    Article  PubMed  Google Scholar 

  11. Henry SP, Beattie G, Yeh G, Chappel A, Giclas P, Mortari A, Jagels MA, Kornbrust DJ, Levin AA (2002) Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide. Int Immunopharmacol 2(12):1657–1666

    Article  CAS  PubMed  Google Scholar 

  12. Chanan-Khan A, Szebeni J, Savay S, Liebes L, Rafique NM, Alving CR, Muggia FM (2003) Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil®): possible role in hypersensitivity reactions. Ann Oncol 14(9):1430–1437

    Article  CAS  PubMed  Google Scholar 

  13. Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC, Benoit JP (2006) Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. J Biomed Mater Res A 78(3):620–628. doi:10.1002/jbm.a.30711

    Article  CAS  PubMed  Google Scholar 

  14. Bartlett DW, Davis ME (2007) Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bioconjug Chem 18(2):456–468. doi:10.1021/bc0603539

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Nagayama S, Ogawara K, Fukuoka Y, Higaki K, Kimura T (2007) Time-dependent changes in opsonin amount associated on nanoparticles alter their hepatic uptake characteristics. Int J Pharm 342(1–2):215–221. doi:10.1016/j.ijpharm.2007.04.036

    Article  CAS  PubMed  Google Scholar 

  16. Al-Hanbali O, Rutt KJ, Sarker DK, Hunter AC, Moghimi SM (2006) Concentration dependent structural ordering of poloxamine 908 on polystyrene nanoparticles and their modulatory role on complement consumption. J Nanosci Nanotechnol 6(9–10):3126–3133

    Article  CAS  PubMed  Google Scholar 

  17. Bertholon I, Vauthier C, Labarre D (2006) Complement activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length, and type of polysaccharide. Pharm Res 23(6):1313–1323. doi:10.1007/s11095-006-0069-0

    Article  CAS  PubMed  Google Scholar 

  18. Xu Y, Ma M, Ippolito GC, Schroeder HW Jr, Carroll MC, Volanakis JE (2001) Complement activation in factor D-deficient mice. Proc Natl Acad Sci U S A 98(25):14577–14582. doi:10.1073/pnas.261428398

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Szebeni J, Bedocs P, Rozsnyay Z, Weiszhar Z, Urbanics R, Rosivall L, Cohen R, Garbuzenko O, Bathori G, Toth M, Bunger R, Barenholz Y (2012) Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome. Nanomedicine 8(2):176–184. doi:10.1016/j.nano.2011.06.003

    Article  CAS  PubMed  Google Scholar 

  20. Szebeni J, Baranyi L, Savay S, Milosevits J, Bunger R, Laverman P, Metselaar JM, Storm G, Chanan-Khan A, Liebes L, Muggia FM, Cohen R, Barenholz Y, Alving CR (2002) Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies. J Liposome Res 12(1–2):165–172. doi:10.1081/lpr-120004790

    Article  CAS  PubMed  Google Scholar 

  21. Dobrovolskaia MA, McNeil SE (2013) Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release 172(2):456–466. doi:10.1016/j.jconrel.2013.05.025

    Article  CAS  PubMed  Google Scholar 

  22. Neun BW, Dobrovolskaia MA (2011) Qualitative analysis of total complement activation by nanoparticles. Methods Mol Biol 697:237–245. doi:10.1007/978-1-60327-198-1_25

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

This project has been funded in whole or in part by federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government.

Author information

Authors and Affiliations

  1. Cancer Research Technology Program, Nanotechnology Characterization Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, P.O. Box B, Frederick, MD, 21702, USA

    Barry W. Neun, Anna N. Ilinskaya & Marina A. Dobrovolskaia

Authors
  1. Barry W. Neun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna N. Ilinskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marina A. Dobrovolskaia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marina A. Dobrovolskaia .

Editor information

Editors and Affiliations

  1. Nanotechnology Characterization Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA

    Scott E. McNeil

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media LLC

About this protocol

Cite this protocol

Neun, B.W., Ilinskaya, A.N., Dobrovolskaia, M.A. (2018). Analysis of Complement Activation by Nanoparticles. In: McNeil, S. (eds) Characterization of Nanoparticles Intended for Drug Delivery. Methods in Molecular Biology, vol 1682. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7352-1_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7352-1_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7350-7

  • Online ISBN: 978-1-4939-7352-1

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation